Follow
Daniel W. Chan
Title
Cited by
Cited by
Year
Natural history of progression after PSA elevation following radical prostatectomy
CR Pound, AW Partin, MA Eisenberger, DW Chan, JD Pearson, PC Walsh
Jama 281 (17), 1591-1597, 1999
36111999
The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer
AW Partin, J Yoo, HB Carter, JD Pearson, DW Chan, JI Epstein, PC Walsh
The Journal of urology 150 (1), 110-114, 1993
15611993
Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease
HB Carter, JD Pearson, EJ Metter, LJ Brant, DW Chan, R Andres, ...
Jama 267 (16), 2215-2220, 1992
15601992
Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer
J Li, Z Zhang, J Rosenzweig, YY Wang, DW Chan
Clinical chemistry 48 (8), 1296-1304, 2002
13552002
Proteogenomics connects somatic mutations to signalling in breast cancer
P Mertins, DR Mani, KV Ruggles, MA Gillette, KR Clauser, P Wang, ...
Nature 534 (7605), 55-62, 2016
13162016
Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer
Z Zhang, RC Bast Jr, Y Yu, J Li, LJ Sokoll, AJ Rai, JM Rosenzweig, ...
Cancer research 64 (16), 5882-5890, 2004
12722004
Proteogenomic characterization of human colon and rectal cancer
B Zhang, J Wang, X Wang, J Zhu, Q Liu, Z Shi, MC Chambers, ...
Nature 513 (7518), 382-387, 2014
12472014
Immunosensors—principles and applications to clinical chemistry
PB Luppa, LJ Sokoll, DW Chan
Clinica chimica acta 314 (1-2), 1-26, 2001
9552001
Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 …
GS Omenn, DJ States, M Adamski, TW Blackwell, R Menon, H Hermjakob, ...
Proteomics 5 (13), 3226-3245, 2005
9032005
Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia
AW Partin, HB Carter, DW Chan, JI Epstein, JE Oesterling, RC Rock, ...
The Journal of urology 143 (4), 747-752, 1990
8361990
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers
CM Sturgeon, MJ Duffy, UH Stenman, H Lilja, N Brunner, DW Chan, ...
Clinical chemistry 54 (12), e11-e79, 2008
781*2008
Integrated proteogenomic characterization of human high-grade serous ovarian cancer
H Zhang, T Liu, Z Zhang, SH Payne, B Zhang, JE McDermott, JY Zhou, ...
Cell 166 (3), 755-765, 2016
7442016
Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy
JE Oesterling, DW Chan, JI Epstein, AW Kimball Jr, DJ Bruzek, RC Rock, ...
The Journal of urology 139 (4), 766-772, 1988
7111988
Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group
MK Tuck, DW Chan, D Chia, AK Godwin, WE Grizzle, KE Krueger, W Rom, ...
Journal of proteome research 8 (1), 113-117, 2009
6962009
HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples
AJ Rai, CA Gelfand, BC Haywood, DJ Warunek, J Yi, MD Schuchard, ...
Proteomics 5 (13), 3262-3277, 2005
5912005
A multicenter study of [-2] pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to …
WJ Catalona, AW Partin, MG Sanda, JT Wei, GG Klee, CH Bangma, ...
The Journal of urology 185 (5), 1650-1655, 2011
5472011
Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology
C Rosty, L Christa, S Kuzdzal, WM Baldwin, ML Zahurak, F Carnot, ...
Cancer research 62 (6), 1868-1875, 2002
5072002
Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach
SA Carr, SE Abbatiello, BL Ackermann, C Borchers, B Domon, ...
Molecular & Cellular Proteomics 13 (3), 907-917, 2014
5042014
Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of …
OJ Semmes, Z Feng, BL Adam, LL Banez, WL Bigbee, D Campos, ...
Clinical Chemistry 51 (1), 102-112, 2005
4372005
Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges
AK Füzéry, J Levin, MM Chan, DW Chan
Clinical proteomics 10 (1), 1-14, 2013
4292013
The system can't perform the operation now. Try again later.
Articles 1–20